Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors

Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors

US Patent 11065257 · Granted Jul 20, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia2024
Substituted dihydrothienopyrimidines and their use as phosphodiesterase inhibito2024
Small molecule modulators of IL-172022
Small molecule modulators of IL-172022
Substituted dihydrothienopyrimidines and their use as phosphodiesterase inhibito2022
Substituted tetrahydropyran dihydrothienopyrimidines and their use as phosphodie2022
Substituted tetrahydropyran dihydrothienopyrimidines and their use as phosphodie2022
Substituted tetrahydropyran dihydrothienopyrimidines and their use as phosphodie2022
Substituted azetidine dihydrothienopyrimidines and their use as phosphodiesteras2022
Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia2021
Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors2021
Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors2021